基于网络药理学和分子对接的怀孕终止中misoprostol的多目标机制
Rui Zhang1, Jing Cao1, Lanlan Li1
1Department of Pharmacy, Gansu Provincial Maternity and Child-care Hospital, Lanzhou, China.
African journal of reproductive health
|April 7, 2024
概括
用于终止妊娠的药物米索普罗斯托尔通过收缩子宫来起作用. 这项研究揭示了其核心治疗点和参与该过程的分子途径.
科学领域:
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 米索普罗斯托尔是一种已知诱导子宫收缩以终止怀孕的前列腺素类似物.
- 在终止怀孕中弥苏的作用背后的精确分子机制尚未被系统评估.
研究的目的:
- 为了阐明涉及到美索普罗斯托尔诱导妊娠终止的分子标和途径.
- 构建和分析与mizoprostol的作用机制相关的蛋白质-蛋白质相互作用网络.
主要方法:
- 使用数据库 (DrugBank,SwissTargetPrediction,PharmMapper,GeneCards) 来识别使用米索普罗斯托尔和终止怀孕的目标.
- 使用STRING数据库构建了蛋白质-蛋白质相互作用网络,并进行了分子对接以验证目标.
- 进行了基因本体学 (GO) 功能和基因和基因组的京都百科全书 (KEGG) 路径丰富分析.
主要成果:
- 确定了37个共享的标基因和134个潜在标的网络,其中HSP90AA1,EGFR和MAPK1是核心治疗标.
- 揭示了misoprostol对VEGF信号传递,信号传递和NF-κB信号传递途径的调节.
- 对蛋白质酸化,细胞定位和蛋白质水解调节过程的干扰已被证明.
结论:
- 这项研究在分子层面上全面说明了美苏在终止妊娠中的药理机制.
- 确定了可以进一步研究的关键分子标和途径,以优化mizoprostol的临床应用.
- 建议进行进一步的实验验证,以确认这些发现并改善临床实践.
更多相关视频
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
2.0K
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
2.5K
相关概念视频
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
423
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
423
01:26Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
160
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
160
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
198
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
198
01:17Phase II Reactions: Methylation Reactions
181
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
181
01:24Principles of Drug Action
6.0K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.0K